• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏性鼻炎患者的气道对反复吸入过敏原激发处于“致敏”状态。

Airways of allergic rhinitics are 'primed' to repeated allergen inhalation challenge.

作者信息

Koh Y Y, Lim H S, Min K U, Min Y G

机构信息

Department of Pediatrics, Seoul National University Hospital, Korea.

出版信息

Clin Exp Allergy. 1994 Apr;24(4):337-46. doi: 10.1111/j.1365-2222.1994.tb00244.x.

DOI:10.1111/j.1365-2222.1994.tb00244.x
PMID:8039019
Abstract

The hypothesis that repeated exposure to a specific allergen will further increase bronchial responsiveness to that allergen is supported by indirect evidence. However, it has not been tested as intensely in the laboratory setting, and in some cases, conflicting results are presented. In order to test the hypothesis in the atopic subjects, allergen inhalation challenge tests were performed in 29 house dust mite (Dermatophagoides pteronyssinus) sensitive subjects with allergic rhinitis. Nine subjects displayed early asthmatic responses (EARs) to the first challenge (Group I). Twenty subjects with no significant airway response were submitted to the second challenge 24 h later. Thirteen subjects showed EARs (Group II) and two of these showed late asthmatic responses (LARs) as well. In Group II, there were significant changes between the first and second challenge in post-allergen early phase FEV1 (88.1 +/- 4.2 vs 71.7 +/- 4.2% baseline, P < 0.05) and in post-allergen late phase FEV1 (93.1 +/- 3.4 vs 86.6 +/- 7.8, P < 0.05). After the second challenge, PD20 (provocative dose of methacholine required to produce a 20% fall in FEV1) decreased significantly from the baseline values. When challenged separately with twofold dose of allergen, only three and one of the Group II showed EAR and LAR respectively. PD20 did not change significantly after this challenge. These results indicated that two repeated exposure to allergen dose, which is not enough to cause significant airway responses at a time, may provoke asthmatic airway responses in the subjects with allergic rhinitis and that this effect of priming is not attributed to the cumulative dose but to the consequent effect of repeated allergen exposure.

摘要

反复接触特定过敏原会进一步增加支气管对该过敏原的反应性这一假说得到了间接证据的支持。然而,在实验室环境中尚未对其进行深入测试,并且在某些情况下,出现了相互矛盾的结果。为了在特应性受试者中验证这一假说,对29名对屋尘螨(粉尘螨)敏感且患有过敏性鼻炎的受试者进行了过敏原吸入激发试验。9名受试者对首次激发显示出早期哮喘反应(EARs)(第一组)。24小时后,对另外20名气道反应不明显的受试者进行了第二次激发。其中13名受试者出现了EARs(第二组),其中2名还出现了迟发性哮喘反应(LARs)。在第二组中,过敏原激发后早期FEV1(88.1±4.2 vs 71.7±4.2%基线,P<0.05)和过敏原激发后晚期FEV1(93.1±3.4 vs 86.6±7.8,P<0.05)在首次和第二次激发之间有显著变化。第二次激发后,PD20(使FEV1下降20%所需的乙酰甲胆碱激发剂量)较基线值显著降低。当用两倍剂量的过敏原分别激发时,第二组中只有3名和1名分别出现了EAR和LAR。此次激发后PD20没有显著变化。这些结果表明,两次反复接触不足以一次引起明显气道反应的过敏原剂量,可能会在患有过敏性鼻炎的受试者中引发哮喘气道反应,并且这种致敏作用并非归因于累积剂量,而是归因于反复接触过敏原的后续效应。

相似文献

1
Airways of allergic rhinitics are 'primed' to repeated allergen inhalation challenge.过敏性鼻炎患者的气道对反复吸入过敏原激发处于“致敏”状态。
Clin Exp Allergy. 1994 Apr;24(4):337-46. doi: 10.1111/j.1365-2222.1994.tb00244.x.
2
Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma.屋尘螨过敏患者(无论有无哮喘)中变应原诱导的支气管炎症。
Clin Exp Allergy. 2002 Dec;32(12):1720-7. doi: 10.1046/j.1365-2222.2002.01542.x.
3
Comparison of early and late asthmatic responses between patients with allergic rhinitis and mild asthma.变应性鼻炎和轻度哮喘患者早期与晚期哮喘反应的比较。
Eur Respir J. 1996 May;9(5):905-9. doi: 10.1183/09031936.96.09050905.
4
Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.变应原激发后吸入布地奈德可减轻哮喘患者的迟发哮喘反应,并抑制与之相关的气道对乙酰甲胆碱反应性的增加。
Am J Respir Crit Care Med. 1994 Jun;149(6):1447-51. doi: 10.1164/ajrccm.149.6.8004297.
5
Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis.常年性和季节性变应性鼻炎对乙酰甲胆碱的敏感性和最大反应
Clin Exp Allergy. 1996 Jan;26(1):61-7. doi: 10.1111/j.1365-2222.1996.tb00057.x.
6
Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients.轻度过敏性哮喘患者与过敏性鼻炎患者之间变应原诱导的支气管高反应性和气道炎症变化的比较。
Allergy. 2000 Jun;55(6):531-9. doi: 10.1034/j.1398-9995.2000.00534.x.
7
Nonallergic airway hyperresponsiveness and allergen-specific IgE levels are the main determinants of the early and late asthmatic response to allergen.非过敏性气道高反应性和过敏原特异性 IgE 水平是过敏原引起的早发和迟发哮喘反应的主要决定因素。
J Investig Allergol Clin Immunol. 2013;23(4):267-74.
8
Seasonal variability of non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mites.对屋尘螨过敏的哮喘患者非特异性支气管反应性的季节性变化
Allergy Asthma Proc. 2001 Jan-Feb;22(1):5-9. doi: 10.2500/108854101778249221.
9
Effect of allergen inhalation on the maximal response plateau of the dose-response curve to methacholine.变应原吸入对乙酰甲胆碱剂量反应曲线最大反应平台的影响。
Am Rev Respir Dis. 1992 Sep;146(3):565-9. doi: 10.1164/ajrccm/146.3.565.
10
Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge.特应性皮炎患者在变应原吸入激发试验后的支气管和皮肤反应。
Clin Exp Allergy. 1997 Sep;27(9):1043-51. doi: 10.1111/j.1365-2222.1997.tb01256.x.

引用本文的文献

1
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.国际过敏与鼻科学学会共识声明:变应性鼻炎。
Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073.
2
Local nasal specific immunotherapy for allergic rhinitis.变应性鼻炎的局部鼻内特异性免疫治疗。
Allergy Asthma Clin Immunol. 2006 Sep 15;2(3):117-23. doi: 10.1186/1710-1492-2-3-117.
3
Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.变应性鼻炎的持续低度炎症:对当前治疗策略的影响。
Clin Exp Immunol. 2009 Dec;158(3):260-71. doi: 10.1111/j.1365-2249.2009.04017.x. Epub 2009 Aug 25.